NOVOZYMES A/S: cash_and_equivalents

Value{"amount": 260800000.0, "concept": "ifrs-full:CashAndCashEquivalents"}
Period (as of 2024-06-30)
Statuscurrent
EntityNOVOZYMES A/S
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference: esef:529900T6WNZXD2R3JW38:2025-09-30
Retrieved: 2026-08-23T22:58:36.155006+02:00
Raw response sha256: 8b248b9feb6411f0562ee0aad5df7ead…
Cite as: FACTANKER, https://factanker.com/fact/13a3ee4a-7283-4c09-9475-d37fcd26fa87

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies